Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system

Medical Mycology

Volumn 44, Issue 1, 2006, Pages 1-11

  Uicker, William ^a   McCracken, James P ^a   Buchanan, Kent L ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

CD4 T Cells; Chemokines; Cryptococcus; Cytokines; Immunity; iNOS

Indexed keywords

CD4 ANTIGEN; FUNGUS ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL ISOLATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; FEMALE; FUNGAL MENINGITIS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MENINGOENCEPHALITIS; MOUSE; NEUROPROTECTION; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHEMOKINES; COLONY COUNT, MICROBIAL; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MENINGITIS, CRYPTOCOCCAL; MICE; MICE, INBRED CBA; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; SURVIVAL ANALYSIS;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 31344449263     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500088424     Document Type: Article

References (37)

1. Lewis, JL and Rabinovich, S. (1972) The wide spectrum of cryptococcal infections Am J Med, 53, pp. 315-322.
2. Diamond, RD and Bennett, JE. (1974) Prognostic factors in cryptococcal meningitis. A study in 111 cases Ann Intern Med, 80, pp. 176-181.
3. Gupta, RK and Khan, ZU and Nampoory, MR and (2004) Cutaneous cryptococcosis in a diabetic renal transplant recipient J Med Microbiol, 53, pp. 445-449.
4. Kovacs, JA and Kovacs, AA and Polis, M and (1985) Cryptococcosis in the acquired immunodeficiency syndrome Ann Intern Med, 103, pp. 533-538.
5. Dev, D and Basran, GS and Slater, D and (1994) Immunodeficiency without HIV. Consider HIV negative immunodeficiency in cryptococcosis BMJ, 308, pp. 1436.
6. Casadevall, A and Perfect, JR.(1998) Cryptococcus neoformans. Washington DC: ASM Press.
7. Kwon-Chung, KJ.(1992) Cryptococcosis. In Medical Mycology. (pp. 397-446). Philadelphia: Lea & Febiger.
8. Powderly, WG. (1992) Therapy for cryptococcal meningitis in patients with AIDS Clin Infect Dis, 14, pp. S54-S59.
9. Spitzer, ED and Spitzer, SG and Freundlich, LF and Casadevall, A. (1993) Persistence of initial infection in recurrent Cryptococcus neoformans meningitis Lancet, 341, pp. 595-596.
10. Mukherjee, J and Pirofski, LA and Scharff, MD and Casadevall, A. (1993) Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection Proc Natl Acad Sci USA, 90, pp. 3636-3640.
11. Hobbs, MM and Perfect, JR and Granger, DL and Durack, DT. (1990) Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis Infect Immun, 58, pp. 2115-2119.
12. + T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans J Immunol, 152, pp. 2344-2350.
13. Aguirre, K and Havell, EA and Gibson, GW and Johnson, LL. (1995) Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice Infect Immun, 63, pp. 1725-1731.
14. + T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice Infect Immun, 68, pp. 456-462.
15. Uicker, WC and Doyle, HA and McCracken, JP and (2005) Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans Medical Mycology, 43, pp. 27-38.
16. Murphy, JW and Cozad, GC. (1972) Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique Infect Immun, 5, pp. 896-901.
17. Buchanan, KL and Murphy, JW. (1993) Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response Infect Immun, 61, pp. 2854-2865.
18. + T cells during a pulmonary Cryptococcus neoformans infection J Immunol, 155, pp. 4790-4797.
19. Olszewski, MA and Huffnagle, GB and Traynor, TR and (2001) Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines Infect Immun, 69, pp. 6256-6263.
20. Olszewski, MA and Huffnagle, GB and McDonald, RA and (2000) The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection J Immunol, 165, pp. 6429-6436.
21. Huffnagle, GB and Strieter, RM and McNeil, LK and (1997) Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection J Immunol, 159, pp. 318-327.
22. Doyle, HA and Murphy, JW. (1997) MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans J Leukoc Biol, 61, pp. 147-155.
23. Huffnagle, GB and McNeil, LK. (1999) Dissemination of C. neoformans to the central nervous system: Role of chemokines, Th1 immunity and leukocyte recruitment J Neurovirol, 5, pp. 76-81.
24. Huffnagle, GB and McNeil, LK and McDonald, RA and (1999) Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans J Immunol, 163, pp. 4642-4646.
25. Huffnagle, GB and Toews, GB and Burdick, MD and (1996) Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans J Immunol, 157, pp. 4529-4536.
26. Kawakami, K and Kohno, S and Kadota, J and (1995) T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: Involvement of IFN-gamma and its protective effect against cryptococcal infection Microbiol Immunol, 39, pp. 135-143.
27. Kawakami, K and Kinjo, Y and Yara, S and (2001) Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis Infect Immun, 69, pp. 6643-6650.
28. Kawakami, K and Qureshi, MH and Koguchi, Y and (1999) Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18 Cell Immunol, 193, pp. 9-16.
29. Kawakami, K and Qureshi, MH and Zhang, T and (1999) Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans Clin Exp Immunol, 117, pp. 113-122.
30. Kawakami, K and Tohyama, M and Teruya, K and (1996) Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans FEMS Immunol Med Microbiol, 13, pp. 123-130.
31. Bauman, SK and Huffnagle, GB and Murphy, JW. (2003) Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response Infect Immun, 71, pp. 68-74.
32. Ransohoff, RM and Kivisakk, P and Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system Nat Rev Immunol, 3, pp. 569-581.
33. Blasi, E and Barluzzi, R and Mazzolla, R and (1995) Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line J Neuroimmunol, 58, pp. 111-116.
34. Lee, SC and Kress, Y and Dickson, DW and Casadevall, A. (1995) Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody J Neuroimmunol, 62, pp. 43-52.
35. Lee, SC and Dickson, DW and Brosnan, CF and Casadevall, A. (1994) Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism J Exp Med, 180(1), pp. 365-369.
36. Alspaugh, JA and Granger, DL. (1991) Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis Infect Immun, 59, pp. 2291-2296.
37. Barluzzi, R and Mazzolla, R and Brozzetti, A and (1997) A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis J Neuroimmunol, 79, pp. 37-48.